Clinical Trial Update: Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing acetazolamide versus sodium bicarbonate for prevention of contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Contrast Induced Nephropathy | Phase 2 | Status: COMPLETED